Clinical Trial Update: Primary Radiotherapy In MEtastatic Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating primary radiotherapy for metastatic non-small cell lung cancer; trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Trans Tasman Radiation Oncology Group | Conditions: Carcinoma, Non-Small-Cell Lung (NSCLC) | Phase 3 | Status: NOT_YET_RECRUITING